Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Technology Development
Thermo Fisher Scientific prepared to expand its work at manufacturing facility
Thermo Fisher Scientific executives voiced hopes for expanding work to help combat diseases at its giant $180 million viral vector manufacturing site in Plainville, MA.
September 27, 2023
Applied DNA buys Spindle Biotech to improve mRNA production offering
New York-based Applied DNA will integrate its LinearDNA platform and Spindle’s RNAP to make LineaIVT, a platform that it claims will address challenges facing manufacturers of mRNA vaccines and therapies.
July 20, 2023
Audere receives $9.35M grant to develop RDT results interpretation tool
The grant will support platform development and artificial intelligence model creation to generate a comprehensive set of algorithms for malaria rapid diagnostic tests, the firm said.
April 18, 2023
DnaNudge, Mylab to develop MDx tests for diabetic foot infections, other health conditions
DnaNudge anticipates that its multiplex tests will enable health teams to identify the specific microbiological organisms responsible for each foot infection, providing antimicrobial resistance results in just over an hour.
March 13, 2023
At USCAP 2023, ProPhase Labs to present data about esophageal cancer screening test
The upcoming presentation in New Orleans is scheduled for March 14 and entitled "Targeted Mass Spectrometry of Barrett's Esophagus Reveals High-Fidelity Combinatorial Molecular Correlates."
March 13, 2023
Sherlock Biosciences nabs additional patent rights to Cas12 enzyme for CRISPR diagnostics
Sherlock Biosciences has exclusive U.S. rights to the patent from Shanghai-based Tolo Biotech, as well as to additional intellectual property for Cas12 and Cas13 obtained from the Broad Institute.
February 21, 2023
Duke University developing blood test to detect osteoarthritis progression in the knee
A new blood test may identify osteoarthritis progression in the knee more accurately than other methods, potentially advancing research and new therapies.
January 30, 2023
NIH funds eight studies to advance rapid diagnosis of COVID-19-related inflammatory syndrome in children
The awards are part of the Rapid Acceleration of Diagnostics Radical (RADx-rad) program to support new, non-traditional approaches and new uses of existing tools to address gaps in COVID-19 testing and surveillance.
January 9, 2023
FYR, Medicover partner to expand into North America
The collaboration will support pharmaceutical companies with clinical trial assay development and implementation, codevelopment of novel diagnostic technologies, and companion diagnostic testing services.
August 30, 2022
NanoDx, SkyWater launch nano biosensor
The companies said that as a result of the development, NanoDx is ready to prepare and submit the product for review by the U.S. Food and Drug Administration (FDA) with the aim of eventually commercializing a product based on the technology.
August 25, 2022
PathAI and Bristol Myers Squibb extend AI partnership
"We will build on our work using AI-based pathology in translational research and validate the use of this technology through clinical trials and diagnostic development," Andy Beck, cofounder and CEO of PathAI, said in a statement.
August 24, 2022
Satio partners with nonprofit institute in Senegal
Under the deal, the company's SatioRx intradermal patches will be combined with Institut Pasteur de Dakar technologies to drive clinical development and access to vaccine patches. The partnership will also encompass diagnostic patches for blood sampling, genetic testing, and pathogen surveillance, Satio said.
August 22, 2022
Page 1 of 4
Next Page
